Dr. Samer Asem Haddad, MD

Dr. Haddad practices at Robert Wood Johnson University Hospital Hamilton in Hamilton, New Jersey, part of RWJBarnabas Health.

Dr. Haddad's NPI, 1780067280, was assigned on July 1, 2015. Dr. Haddad holds New Jersey license 25MA11518100.

Dr. Haddad's primary practice is Robert Wood Johnson University Hospital Hamilton, at One Hamilton Health Place, Hamilton, NJ 08690 in Mercer County. The practice phone is (609) 586-7900. Dr. Haddad also practices at Robert Wood Johnson University Hospital - Hamilton, 1 Hamilton Health Pl, Trenton, NJ 08690.

Dr. Haddad's primary practice is Robert Wood Johnson University Hospital Hamilton in Hamilton, New Jersey, part of RWJBarnabas Health. Dr. Haddad is also affiliated with Havasu Regional Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Haddad to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haddad practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Haddad's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Haddad's licenses on file in 2 states: New Jersey and Arizona.

CMS data shows 1,331 Medicare services from Dr. Haddad across 7 procedure codes in 2024, for 421 Medicare patients. Medicare paid $130,718 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 421 Medicare patients who saw Dr. Haddad in 2024. The largest group is 75 to 84, with 135 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Haddad's median patient age at 74, with 59% women.

In 2024, Dr. Haddad wrote 631 Medicare Part D claims for 228 patients. 90% of them were for generic drugs. CMS names the drug for 297 of them, across 15 drugs with 11 or more claims each, at $9,377 in total drug cost. In 2023, CMS named 165 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Haddad for performance year 2024, reported as part of a group. Dr. Haddad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 10 general payments to Dr. Haddad from 6 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $125.